302 related articles for article (PubMed ID: 16033330)
21. Monoclonal Antibodies 1G12 and 6A12 to the N-domain of human angiotensin-converting enzyme: fine epitope mapping and antibody-based detection of ACE inhibitors in human blood.
Balyasnikova IV; Skirgello OE; Binevski PV; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM
J Proteome Res; 2007 Apr; 6(4):1580-94. PubMed ID: 17326675
[TBL] [Abstract][Full Text] [Related]
22. The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity.
Woodman ZL; Schwager SL; Redelinghuys P; Carmona AK; Ehlers MR; Sturrock ED
Biochem J; 2005 Aug; 389(Pt 3):739-44. PubMed ID: 15813703
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
Ehlers MR; Riordan JF
Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
[TBL] [Abstract][Full Text] [Related]
24. Exclusion of angiotensin I-converting enzyme as a candidate gene involved in exudative inflammatory resistance in F344/N rats.
Jafarian-Tehrani M; Listwak S; Barrientos RM; Michaud A; Corvol P; Sternberg EM
Mol Med; 2000 Apr; 6(4):319-31. PubMed ID: 10949912
[TBL] [Abstract][Full Text] [Related]
25. Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method.
Andújar-Sánchez M; Jara-Pérez V; Cámara-Artigas A
FEBS Lett; 2007 Jul; 581(18):3449-54. PubMed ID: 17618628
[TBL] [Abstract][Full Text] [Related]
26. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
Michaud A; Williams TA; Chauvet MT; Corvol P
Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
[TBL] [Abstract][Full Text] [Related]
27. The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition.
Lubbe L; Sewell BT; Sturrock ED
FEBS J; 2016 Nov; 283(21):3941-3961. PubMed ID: 27636235
[TBL] [Abstract][Full Text] [Related]
28. Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site.
Danilov S; Jaspard E; Churakova T; Towbin H; Savoie F; Wei L; Alhenc-Gelas F
J Biol Chem; 1994 Oct; 269(43):26806-14. PubMed ID: 7523412
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril.
Kim HM; Shin DR; Yoo OJ; Lee H; Lee JO
FEBS Lett; 2003 Mar; 538(1-3):65-70. PubMed ID: 12633854
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
31. Measuring angiotensin-I converting enzyme inhibitory activity by micro plate assays: comparison using marine cryptides and tentative threshold determinations with captopril and losartan.
Ben Henda Y; Labidi A; Arnaudin I; Bridiau N; Delatouche R; Maugard T; Piot JM; Sannier F; Thiéry V; Bordenave-Juchereau S
J Agric Food Chem; 2013 Nov; 61(45):10685-90. PubMed ID: 24131339
[TBL] [Abstract][Full Text] [Related]
32. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
[TBL] [Abstract][Full Text] [Related]
33. Structural basis of the lisinopril-binding specificity in N- and C-domains of human somatic ACE.
Fernandez JH; Hayashi MA; Camargo AC; Neshich G
Biochem Biophys Res Commun; 2003 Aug; 308(2):219-26. PubMed ID: 12901857
[TBL] [Abstract][Full Text] [Related]
34. Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril.
Watermeyer JM; Kröger WL; O'Neill HG; Sewell BT; Sturrock ED
Biochem J; 2010 Apr; 428(1):67-74. PubMed ID: 20233165
[TBL] [Abstract][Full Text] [Related]
35. [Angiotensin converting enzyme (kininase II). Molecular and physiological aspects].
Costerousse O; Jaspard E; Allegrini J; Wei L; Alhenc-Gelas F
C R Seances Soc Biol Fil; 1992; 186(6):586-98. PubMed ID: 1339589
[TBL] [Abstract][Full Text] [Related]
36. Drosophila melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of the mammalian homologue and does not require glycosylation for secretion and enzymic activity.
Williams TA; Michaud A; Houard X; Chauvet MT; Soubrier F; Corvol P
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):125-31. PubMed ID: 8761461
[TBL] [Abstract][Full Text] [Related]
37. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
Shalaby SM; Zakora M; Otte J
J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
[TBL] [Abstract][Full Text] [Related]
38. [Structure and physiological significance of angiotensin converting enzyme domains].
Eliseeva IuE; Kugaevskaia EV
Biomed Khim; 2009; 55(4):397-414. PubMed ID: 20000120
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme.
Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843
[TBL] [Abstract][Full Text] [Related]
40. Effect of peptide-based captopril analogues on angiotensin converting enzyme activity and peroxynitrite-mediated tyrosine nitration.
Bhuyan BJ; Mugesh G
Org Biomol Chem; 2011 Jul; 9(14):5185-92. PubMed ID: 21629912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
